CytomX Therapeutics
CTMX
$1.89
Share price
-5.50%
Change (1 day)
6.78%
Change (1 year)
Categories
CytomX Therapeutics (CTMX) - Cash on Hand
Cash on Hand as of December 2023 : $0.17 B
According to CytomX Therapeutics
's latest financial reports the company has $0.17 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
CytomX Therapeutics - Cash on Hand chart (from 2014 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.17 B | -9.88% |
| 2022-12-31 | $0.19 B | -36.56% |
| 2021-12-31 | $0.30 B | -3.45% |
| 2020-12-31 | $0.31 B | 6.74% |
| 2019-12-31 | $0.29 B | -32.1% |
| 2018-12-31 | $0.43 B | 16.58% |
| 2017-12-31 | $0.37 B | 105.62% |
| 2016-12-31 | $0.18 B | -2.56% |
| 2015-12-31 | $0.18 B | 189.94% |
| 2014-12-31 | $64.39 M | 639.93% |
| 2013-12-31 | $8.7 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 19.30% | 🇺🇸 USA |